News

Published on 23 Feb 2024 on Zacks via Yahoo Finance

5 Top-Ranked Stocks That Have More Than Doubled Year to Date


Article preview image

Wall Street has been roaring higher, driven by a solid earnings season, a resilient economy and a technology surge. Both the S&P 500 and Dow Jones are at all-time highs, while the tech-heavy Nasdaq Composite Index is just below its record peak.The gains have been broad-based across various segments and many stocks have more than doubled this year. We have highlighted five stocks that have a Zacks Rank #1 (Strong Buy) or 2 (Buy), a Momentum Score of B or better and saw positive earnings estimate revisions for the current fiscal year over the past 30 days, suggesting continued outperformance. These are Equillium, Inc. EQ, Phunware Inc. PHUN, Super Micro Computer, Inc. SMCI, Vaxart, Inc. VXRT and Dianthus Therapeutics Inc. DNTH. You can see the complete list of today’s Zacks #1 Rank stocks here.

Solid Earnings

Total fourth-quarter earnings of the 402 S&P 500 members who have reported results so far increased 4.9% from the prior-year period on 3.4% higher revenues. Of the companies that reported results, 78.6% beat EPS estimates and 64.4% surpassed revenue estimates. The pace of earnings and revenue growth represents an acceleration from the last couple of quarters, with the technology sector being a major contributor. Notably, the earnings growth is the best growth rate for the S&P 500 companies since the 6.2% earnings growth rate in the second quarter of 2022.

NASDAQ.VXRT price evolution
NASDAQ.EQ price evolution
NASDAQ.PHUN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees...

Oppenheimer initiated coverage on Vaxart Inc. (NASDAQ:VXRT), an American biotechnology company...

Benzinga · via Yahoo Finance 24 Aug 2024

Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity...

Vaxart, Inc. (NASDAQ:VXRT) shares traded higher in the premarket session on Friday, up more than ...

Benzinga · via Yahoo Finance 23 Jun 2024

While institutions invested in Vaxart, Inc. (NASDAQ:VXRT) benefited from last...

Key Insights Significant control over Vaxart by retail investors implies that the general public ...

Simply Wall St. · via Yahoo Finance 23 Jun 2024

Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?

The 2024 presidential election is shaping up to be just as exciting and contentious the 2020 cont...

InvestorPlace via Yahoo Finance 6 Apr 2024

Estimating The Intrinsic Value Of Vaxart, Inc. (NASDAQ:VXRT)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Vaxart fair value estimate is US$0.90Wit...

Simply Wall St. via Yahoo Finance 17 Mar 2024

Vaxart, Inc. (NASDAQ:VXRT) Q4 2023 Earnings Call Transcript

Vaxart, Inc. (NASDAQ:VXRT) Q4 2023 Earnings Call Transcript March 14, 2024 Vaxart, Inc.  isn't on...

Insider Monkey via Yahoo Finance 15 Mar 2024

VAXART, INC. (VXRT) is a Great Momentum Stock: Should You Buy?

Momentum investing is all about the idea of following a stock's recent trend, which can be in eit...

Zacks via Yahoo Finance 26 Feb 2024

5 Top-Ranked Stocks That Have More Than Doubled Year to Date

Wall Street has been roaring higher, driven by a solid earnings season, a resilient economy and a...

Zacks via Yahoo Finance 23 Feb 2024

VAXART, INC. (VXRT) Now Trades Above Golden Cross: Time to Buy?

VAXART, INC. (VXRT) reached a significant support level, and could be a good pick for investors f...

Zacks via Yahoo Finance 20 Feb 2024

Strong week for Vaxart (NASDAQ:VXRT) shareholders doesn't alleviate pain of three-year loss

Vaxart, Inc. (NASDAQ:VXRT) shareholders should be happy to see the share price up 10% in the last...

Simply Wall St. via Yahoo Finance 22 Aug 2023